New Story
Glenmark Pharma down 1% despite tentative USFDA nod for multiple sclerosis drug
October 8, 2019 | By Moneycontrol.com
business
The company's portfolio consists of 161 products authorised for distribution in the US marketplace.
:
Shares of Glenmark Pharma declined over 1 percent intraday on October 9. The company has received tentative approval by the United States Food  and Drug Administration (USFDA) for Dimethyl Fumarate delayedrelease capsules. The approval to Glenmark Pharmaceut
...
It’s time to compare and apply for the best loan offers at Afinoz. We are a leading online financial marketplace for Personal Loans, Business Loan,Education Loan,Home Loan & Car Loan and Investment Products. Our system intelligence and the automated system offers the best options to you for the real-time tracking of your loan application in an easy manner. Stay tuned to latest updates in the industry at Afinoz.com
blog
BSNL VRS scheme: Employees to get lumpsum retireme...
November 20, 2019
blog
Sebi hikes PMS investment size to Rs 50 lakh, tigh...
November 20, 2019
blog
Sebi tightens norms on default disclosure, rights ...
November 20, 2019
blog
Mukesh Ambani's Reliance Industries becomes world'...
November 20, 2019
blog
Piramal gets waiver on debt contract after offerin...
November 20, 2019
blog
RIL share price adds 2% as Credit Suisse raises ta...
November 20, 2019
blog
BSNL to raise tariff from December
November 20, 2019
blog
With over 1,000 kitchens in a year, Swiggy invests...
November 20, 2019
Check your Eligibility
To check how much loan you can get.
Loan Amount
Monthly Income?
EMI's
Email
Company Name
Mobile Number
Verify

Related News:-